MAB6789SP
Human NLRP3/NALP3 Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB6789SP-Each-of-1 | In Stock | ₹ 17,154.78 |
MAB6789SP - Each of 1
In Stock
Quantity
1
Base Price: ₹ 17,154.78
GST (18%): ₹ 3,087.86
Total Price: ₹ 20,242.64
Antigen
NLRP3/NALP3
Classification
Monoclonal
Concentration
LYOPH
Dilution
Immunocytochemistry 8-25 ug/mL
Gene Accession No.
Q96P20
Gene Symbols
NLRP3
Immunogen
E. coli-derived recombinant human NLRP3/NALP3 Ala4-Val223 Accession # Q96P20
Quantity
25 μg
Primary or Secondary
Primary
Test Specificity
Detects human NLRP3/NALP3 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) NALP1, 2, 5, rhNALP3 (aa 540-689), or recombinant mouse NALP3 is observed.
Target Species
Human
Form
Purified
Applications
Immunocytochemistry
Clone
652514
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Gene ID (Entrez)
114548
Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG1
Related Products
Description
- NLRP3/NALP3 Monoclonal specifically detects NLRP3/NALP3 in Human samples
- It is validated for Immunocytochemistry.
Compare Similar Items
Show Difference
Antigen: NLRP3/NALP3
Classification: Monoclonal
Concentration: LYOPH
Dilution: Immunocytochemistry 8-25 ug/mL
Gene Accession No.: Q96P20
Gene Symbols: NLRP3
Immunogen: E. coli-derived recombinant human NLRP3/NALP3 Ala4-Val223 Accession # Q96P20
Quantity: 25 μg
Primary or Secondary: Primary
Test Specificity: Detects human NLRP3/NALP3 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) NALP1, 2, 5, rhNALP3 (aa 540-689), or recombinant mouse NALP3 is observed.
Target Species: Human
Form: Purified
Applications: Immunocytochemistry
Clone: 652514
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 114548
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
NLRP3/NALP3
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
Q96P20
Gene Symbols:
NLRP3
Immunogen:
E. coli-derived recombinant human NLRP3/NALP3 Ala4-Val223 Accession # Q96P20
Quantity:
25 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human NLRP3/NALP3 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) NALP1, 2, 5, rhNALP3 (aa 540-689), or recombinant mouse NALP3 is observed.
Target Species:
Human
Form:
Purified
Applications:
Immunocytochemistry
Clone:
652514
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
114548
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: CCL5/RANTES
Classification: Monoclonal
Concentration: __
Dilution: Western Blot 1 ug/mL, Neutralization 0.04-0.12 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
Gene Accession No.: __
Gene Symbols: CCL5
Immunogen: E. coli-derived recombinant human CCL5/RANTES
Quantity: 25 μg
Primary or Secondary: Primary
Test Specificity: Detects human and primate CCL5/RANTES in direct ELISAs and Western blots. When used in combination with the biotinylated anti-human/primate CCL5/RANTES detection antibody (Catalog # BAF278) in sandwich ELISAs, no significant cross-reactivity or interference is observed with recombinant human (rh) ANG, rhCNTF, rh beta-ECGF, rhEGF, mouse (m) EGF, rhEpo, bovine (b) FGF acidic, rhFGF acidic, bFGF basic, rhFGF basic, rhFGF-4, rhG-CSF, rhGM-CSF, recombinant mouse (rm) GM-CSF, rhGRO alpha , rhIFN-gamma , rhIGF-I, rhIGF-II, rhIL-1 alpha , rmIL-1 alpha , rhIL-1 beta , rmIL-1 beta , rhIL-1ra, recombinant rat (rr) IL-1ra, rhIL-2, rhIL-3, rmIL-3, rmIL-4, rhIL-5, rmIL-5, rhIL-6, rmIL-6, rhIL-7, rmIL-7, rhIL-8, rhIL-9, rmIL-9, rhIL-10, rhIL-11, rhLIF, rhMCP-1, rhM-CSF, rhMIP-1 alpha , rmMIP-1 alpha , rhMIP-1 beta , rmMIP-1 beta , rhOSM, human (h) PDGF, pPDGF, rhPDGF-AA, rhPDGF-AB, rhPDGF-BB, rhSCF, rmSCF, rhSLPI, rhTGF-alpha , pTGF-beta 1, hTGF-beta 1, rhTGF-beta 1, pTGF-beta 2, rhTGF-beta 2, recomb
Target Species: Human, Primate
Form: Purified
Applications: Western Blot, Neutralization, ELISA
Clone: 21418
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: chemokine (C-C motif) ligand 5, D17S136Enormally T-expressed, and presumably secreted, EoCP, Eosinophil chemotactic cytokine, RANTES, SISd, SIS-delta, small inducible cytokine A5 (RANTES), small inducible cytokine subfamily A (Cys-Cys), member 5, Small-inducible cytokine A5, T cell-specific protein P228, T-cell specific protein p288, TCP228T-cell-specific protein RANTES
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 6352
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
CCL5/RANTES
Classification:
Monoclonal
Concentration:
__
Dilution:
Western Blot 1 ug/mL, Neutralization 0.04-0.12 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
Gene Accession No.:
__
Gene Symbols:
CCL5
Immunogen:
E. coli-derived recombinant human CCL5/RANTES
Quantity:
25 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human and primate CCL5/RANTES in direct ELISAs and Western blots. When used in combination with the biotinylated anti-human/primate CCL5/RANTES detection antibody (Catalog # BAF278) in sandwich ELISAs, no significant cross-reactivity or interference is observed with recombinant human (rh) ANG, rhCNTF, rh beta-ECGF, rhEGF, mouse (m) EGF, rhEpo, bovine (b) FGF acidic, rhFGF acidic, bFGF basic, rhFGF basic, rhFGF-4, rhG-CSF, rhGM-CSF, recombinant mouse (rm) GM-CSF, rhGRO alpha , rhIFN-gamma , rhIGF-I, rhIGF-II, rhIL-1 alpha , rmIL-1 alpha , rhIL-1 beta , rmIL-1 beta , rhIL-1ra, recombinant rat (rr) IL-1ra, rhIL-2, rhIL-3, rmIL-3, rmIL-4, rhIL-5, rmIL-5, rhIL-6, rmIL-6, rhIL-7, rmIL-7, rhIL-8, rhIL-9, rmIL-9, rhIL-10, rhIL-11, rhLIF, rhMCP-1, rhM-CSF, rhMIP-1 alpha , rmMIP-1 alpha , rhMIP-1 beta , rmMIP-1 beta , rhOSM, human (h) PDGF, pPDGF, rhPDGF-AA, rhPDGF-AB, rhPDGF-BB, rhSCF, rmSCF, rhSLPI, rhTGF-alpha , pTGF-beta 1, hTGF-beta 1, rhTGF-beta 1, pTGF-beta 2, rhTGF-beta 2, recomb
Target Species:
Human, Primate
Form:
Purified
Applications:
Western Blot, Neutralization, ELISA
Clone:
21418
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
chemokine (C-C motif) ligand 5, D17S136Enormally T-expressed, and presumably secreted, EoCP, Eosinophil chemotactic cytokine, RANTES, SISd, SIS-delta, small inducible cytokine A5 (RANTES), small inducible cytokine subfamily A (Cys-Cys), member 5, Small-inducible cytokine A5, T cell-specific protein P228, T-cell specific protein p288, TCP228T-cell-specific protein RANTES
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
6352
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: Protogenin
Classification: Monoclonal
Concentration: __
Dilution: Neutralization 0.4-2.4 ug/mL
Gene Accession No.: Q2VWP7
Gene Symbols: PRTG
Immunogen: Mouse myeloma cell line NS0-derived recombinant human Protogenin Phe36-Ala952 Accession # Q2VWP7
Quantity: 100 μg
Primary or Secondary: Primary
Test Specificity: Detects human Protogenin in direct ELISAs.
Target Species: Human
Form: Supernatant
Applications: Neutralization
Clone: 814403
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: FLJ12795, FLJ13221, FLJ25756, IGDCC5, immunoglobulin superfamily, DCC subclass, member 5, Protein Shen-Dan, protogenin, protogenin homolog (Gallus gallus), PRTG, RPTG, Shen-Dan
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 283659
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
Protogenin
Classification:
Monoclonal
Concentration:
__
Dilution:
Neutralization 0.4-2.4 ug/mL
Gene Accession No.:
Q2VWP7
Gene Symbols:
PRTG
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human Protogenin Phe36-Ala952 Accession # Q2VWP7
Quantity:
100 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human Protogenin in direct ELISAs.
Target Species:
Human
Form:
Supernatant
Applications:
Neutralization
Clone:
814403
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
FLJ12795, FLJ13221, FLJ25756, IGDCC5, immunoglobulin superfamily, DCC subclass, member 5, Protein Shen-Dan, protogenin, protogenin homolog (Gallus gallus), PRTG, RPTG, Shen-Dan
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
283659
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: p15INK4b/CDKN2B
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1 ug/mL, Immunocytochemistry 3-25 ug/mL
Gene Accession No.: P42772
Gene Symbols: CDKN2B
Immunogen: E. coli-derived recombinant human p15INK4b/CDKN2B Arg2-Asp138 Accession # P42772
Quantity: 100 μg
Primary or Secondary: Primary
Test Specificity: Detects human p15INK4b/CDKN2B in direct ELISAs and Western blots. In Western blots, approximately 50% cross-reactivity with recombinant human (rh) p16INK4a and no cross-reactivity with rhp18INK4c or rhp19INK4d is observed.
Target Species: Human
Form: Purified
Applications: Western Blot, Immunocytochemistry
Clone: 651308
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: CDK4I, CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), cyclin-dependent kinases 4 and 6 binding protein, INK4BCDK4B inhibitor, MTS2, MTS-2, MTS2CDK inhibitory protein, Multiple tumor suppressor 2, p14_CDK inhibitor, p14_INK4B, p14-INK4b, p15 CDK inhibitor, p15_INK4B, P15cyclin-dependent kinase 4 inhibitor B, p15INK4b, p15-INK4b, TP15
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 1030
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2b
Antigen:
p15INK4b/CDKN2B
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Western Blot 1 ug/mL, Immunocytochemistry 3-25 ug/mL
Gene Accession No.:
P42772
Gene Symbols:
CDKN2B
Immunogen:
E. coli-derived recombinant human p15INK4b/CDKN2B Arg2-Asp138 Accession # P42772
Quantity:
100 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human p15INK4b/CDKN2B in direct ELISAs and Western blots. In Western blots, approximately 50% cross-reactivity with recombinant human (rh) p16INK4a and no cross-reactivity with rhp18INK4c or rhp19INK4d is observed.
Target Species:
Human
Form:
Purified
Applications:
Western Blot, Immunocytochemistry
Clone:
651308
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
CDK4I, CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), cyclin-dependent kinases 4 and 6 binding protein, INK4BCDK4B inhibitor, MTS2, MTS-2, MTS2CDK inhibitory protein, Multiple tumor suppressor 2, p14_CDK inhibitor, p14_INK4B, p14-INK4b, p15 CDK inhibitor, p15_INK4B, P15cyclin-dependent kinase 4 inhibitor B, p15INK4b, p15-INK4b, TP15
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
1030
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2b